calendar
29,271 catalysts · 9,808 approval · 5,000 device 510k · 4,728 grant · 2,604 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
29,271 catalysts · 9,808 approval · 5,000 device 510k · 4,728 grant · 2,604 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVEN PHARMS INC. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION
Sponsor: DEXCEL PHARMA. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL
Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: GEL. Route: TOPICAL
Sponsor: PFIZER. Form: SWAB. Route: TOPICAL
Sponsor: PFIZER. Form: LOTION. Route: TOPICAL
Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: INVENTIA HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: BIOGEN IDEC. Form: SOLUTION. Route: INTRATHECAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: AM REGENT. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL
Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL
Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: INDIVIOR. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
Sponsor: AMGEN. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: ACTAVIS. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: SPECGX LLC. Form: TABLET. Route: SUBLINGUAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: PFIZER INC. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: ABBVIE INC. Form: VIAL
Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS